← Evidence map

TrialPediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology2025

Effective long-term prophylaxis with lanadelumab in adolescents with hereditary angioedema: EMPOWER/ENABLE.

Raffi Tachdjian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

6 papers cite it

2025
2026
this papertrialcites it

2 trials

Full record →Abstract, authors, funding and every citing paper · PMID 40171989